268 A phase 1 study of retifanlimab (INCMGA00012), a PD-1 inhibitor, in patients with advanced solid tumors: preliminary results in recurrent MSI-high or dMMR endometrial cancer (POD1UM-101)

التفاصيل البيبلوغرافية
العنوان: 268 A phase 1 study of retifanlimab (INCMGA00012), a PD-1 inhibitor, in patients with advanced solid tumors: preliminary results in recurrent MSI-high or dMMR endometrial cancer (POD1UM-101)
المؤلفون: Berton-Rigaud, Dominique, Vergote, Ignace, Pautier, Patricia, Kryzhanivska, Anna, Angelergues, Antoine, Kornacki, Deanna, Dudzisz-Sledz, Monika, Tian, Chuan, Bourayou, Nawel, Selle, Frederic
المصدر: Regular and young investigator award abstracts
بيانات النشر: BMJ Publishing Group Ltd
سنة النشر: 2020
نوع الوثيقة: conference object
اللغة: unknown
DOI: 10.1136/jitc-2020-sitc2020.0268
DOI: 10.1136/jitc-2020-SITC2020.0268
الإتاحة: https://doi.org/10.1136/jitc-2020-sitc2020.0268Test
حقوق: http://creativecommons.org/licenses/by-nc/4.0Test/
رقم الانضمام: edsbas.D3B369C4
قاعدة البيانات: BASE